Sundhed 23 februar 2026

UnitedHealth stock extends slide after bell as Medicare Advantage deadline nears
···

UnitedHealth-aktien falder yderligere efter lukketid, mens frist for Medicare Advantage nærmer sig

UnitedHealth Group shares fell 2.6% to $273.95 in after-hours trading Tuesday, extending a two-day drop of about 5.5%. The decline follows investor concerns over proposed 2027 Medicare Advantage payment rates, with the public comment window closing Feb. 25. Managed-care stocks, including Humana and Elevance, also slipped, even as the broader market rose. UnitedHealth trades on NYSE under ticker UNH.
februar 25, 2026
AbbVie stock (ABBV): FDA clears new Venclexta-Calquence CLL combo — what to watch Monday
···

AbbVie-aktie (ABBV): FDA godkender ny Venclexta-Calquence-kombination til CLL — det skal du holde øje med mandag

The FDA approved a new first-line combination therapy for chronic lymphocytic leukemia using AbbVie’s Venclexta and AstraZeneca’s Calquence, showing improved progression-free survival over standard chemoimmunotherapy. AbbVie shares closed up 0.21% at $224.81 on Friday. Barclays initiated coverage with an overweight rating and $275 price target. Investors await market reaction when trading resumes Monday.
februar 23, 2026